InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,184.91
(
0.08%
)
US TECH 100
17,608.38
(
-0.01%
)
Dow Jones
38,867.99
(
0.04%
)
Brent Oil
83.18
(
-0.36%
)
Bitcoin
63,211.99
(
0.07%
)
Post# of 2969
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

nymostwanted

Send PM Follow Ignore
Followers 31
Posts 2053
Boards Moderated 0
Alias Born 02/14/2014

nymostwanted

Re: None

Wednesday, 02/01/2017 11:02:54 PM

Wednesday, February 01, 2017 11:02:54 PM

Post# of 2969
SAN DIEGO and VANCOUVER, British Columbia , Jan. 30, 2017 /CNW/ -- Sophiris Bio Inc. (SPHS) a biopharmaceutical company developing topsalysin (PRX302) for the treatment of urological diseases, today announced that Randall E. Woods, president and chief executive officer, will present a corporate overview at the BetterInvesting™ Virtual Investor Conference. The presentation will take place on Thursday February 2, 2017 at 1:00 p.m. Eastern Time
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up